Former
Professional Fighters League heavyweight champion Bruno
Cappelozza has been suspended one year for failing an
out-of-competition drug test.
Advertisement
Cappelozza tested positive for clomiphene and its metabolite,
desethyl-clomifene, in a urine sample collected on April 17, 2024.
Clomiphene is in the category of hormone and metabolic modulators
and is banned at all times under the PFL anti-doping policy.
Cappelozza will be eligible to return to active competition on
April 17, 2025.
It’s the second failed drug test for Cappelozza, who tested
positive for drostanolone in relation to a PFL regular season bout
against Matheus
Scheffel on April 7, 2023. That resulted in a nine-month
suspension for the Brazilian, whose knockout of Scheffel was also
overturned to a no contest.
Cappelozza returned to action for the first time since that
sanction at the PFL vs. Bellator Champs event on Feb. 24, when he
suffered a second-round submission loss to former Bellator light
heavyweight champion Vadim
Nemkov. Cappelozza notably captured the PFL heavyweight title
in 2021, winning four consecutive bouts over the course of that
campaign.
Cappelozza is the second PFL athlete to be suspended since the
promotion began its partnership with USADA. In July, Gokhan
Saricam was
suspended for one year after testing positive for clomiphene in
a pair of out-of-competition screenings.